N-(2-((4-(6-(3-fluorophenyl)imidazo[2,1-b]thiazol-5-yl)pyrimidin-2-yl)amino)ethyl)-4-methylbenzenesulfonamide

ID: ALA4778491

PubChem CID: 162661747

Max Phase: Preclinical

Molecular Formula: C24H21FN6O2S2

Molecular Weight: 508.60

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)NCCNc2nccc(-c3c(-c4cccc(F)c4)nc4sccn34)n2)cc1

Standard InChI:  InChI=1S/C24H21FN6O2S2/c1-16-5-7-19(8-6-16)35(32,33)28-12-11-27-23-26-10-9-20(29-23)22-21(17-3-2-4-18(25)15-17)30-24-31(22)13-14-34-24/h2-10,13-15,28H,11-12H2,1H3,(H,26,27,29)

Standard InChI Key:  ARUHTNVJGCRCKR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
   10.2273   -5.6378    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6453   -5.0559    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.4338   -5.8493    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0746   -3.6732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0734   -4.4969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7815   -4.9058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4953   -4.4964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4924   -3.6696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7797   -3.2602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2005   -3.2559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9524   -3.5895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2829   -2.4388    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0856   -2.2657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4954   -2.9747    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2953   -2.8067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3815   -1.9938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6348   -1.6580    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.1260   -4.3891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5208   -4.9398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6957   -5.7414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4795   -5.9934    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0843   -5.4335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9063   -4.6340    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8682   -5.6779    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4739   -5.1206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3626   -3.2606    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.2578   -5.3692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8635   -4.8119    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.2531   -4.5032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0365   -4.7514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6377   -4.1950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4597   -3.3924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6710   -3.1492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0690   -3.7073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0604   -2.8383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10 11  2  0
 11 14  1  0
 13 12  2  0
 12 10  1  0
  8 10  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 13  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 11 18  1  0
 22 24  1  0
 24 25  1  0
  4 26  1  0
 25 27  1  0
 27 28  1  0
 28  2  1  0
  2 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 32 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4778491

    ---

Associated Targets(Human)

SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 508.60Molecular Weight (Monoisotopic): 508.1151AlogP: 4.36#Rotatable Bonds: 8
Polar Surface Area: 101.28Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.40CX Basic pKa: 3.51CX LogP: 4.30CX LogD: 4.29
Aromatic Rings: 5Heavy Atoms: 35QED Weighted: 0.30Np Likeness Score: -2.22

References

1. Abdel-Maksoud MS,Ammar UM,Oh CH.  (2019)  Anticancer profile of newly synthesized BRAF inhibitors possess 5-(pyrimidin-4-yl)imidazo[2,1-b]thiazole scaffold.,  27  (10.0): [PMID:30955995] [10.1016/j.bmc.2019.03.062]

Source